We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Oncogenic Viruses

    Oncogenic viruses can produce tumours in their natural host or experimental animals or malignant transformation of the cell culture. In 1911, Rous...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  2. Exclusion of HDAC1/2 complexes by oncogenic nuclear condensates

    Nuclear condensates have been shown to regulate cell fate control, but its role in oncogenic transformation remains largely unknown. Here we show...

    Junqi Kuang, Pengli Li, ... Duanqing Pei in Molecular Cancer
    Article Open access 27 April 2024
  3. Oncogenic alterations in advanced NSCLC: a molecular super-highway

    Lung cancer ranks among the most common cancers world-wide and is the first cancer-related cause of death. The classification of lung cancer has...

    Alex Friedlaender, Maurice Perol, ... Alfredo Addeo in Biomarker Research
    Article Open access 12 February 2024
  4. Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice

    Recent pan-cancer genomic analyses have identified numerous oncogenic driver mutations that occur in a cell-type and tissue-specific distribution....

    Miriam Mengoni, Andreas Dominik Braun, ... Evelyn Gaffal in Cancer Gene Therapy
    Article Open access 15 February 2024
  5. Elevated aerobic glycolysis driven by p62-mTOR axis promotes arsenic-induced oncogenic phenotypes in human mammary epithelial cells

    Chronic arsenic exposure is considered to increase the risk of breast cancer. p62 is a multifunctional adaptor protein that controls myriad cellular...

    Yongfang Li, Jiao Liu, ... Yuanyuan Xu in Archives of Toxicology
    Article 14 March 2024
  6. Oncogenic Genomic Changes in Cancer

    A common cause of all cancers leads us to a common definition. This definition is mutation. Cancer cells tend to constantly resist irregularity under...
    Abdulbaki Yildirim, Hilal Akalin, Munis Dundar in Oncology: Genomics, Precision Medicine and Therapeutic Targets
    Chapter 2023
  7. Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells

    The highly mutated nature of bladder cancers harboring mutations in chromatin regulatory genes opposing Polycomb-mediated repression highlights the...

    Gizem Ozgun, Tutku Yaras, ... Serap Erkek-Ozhan in Cancer Gene Therapy
    Article 17 January 2024
  8. RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer

    The receptor for advanced glycation end products (RAGE) is implicated in diabetes and obesity complications, as well as in breast cancer (BC)....

    M. G. Muoio, M. Pellegrino, ... E. M. De Francesco in Breast Cancer Research
    Article Open access 17 July 2023
  9. Quantitative Changes in Pro-Oncogenic and Tumor-Suppressing MicroRNA in the Regional Lymph Node during Photodynamic Therapy of Experimental Breast Cancer

    We studied quantitative changes in microRNAs in the axillary lymph node (regional lymph node of the mammary gland) and in the breast tumor tissue....

    A. V. Kabakov, O. V. Kazakov, ... V. N. Cherkas in Bulletin of Experimental Biology and Medicine
    Article 01 February 2024
  10. Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers

    Antibody-drug conjugates (ADCs) are an emerging class of therapeutics for lung cancer, and several are currently in development for this malignancy....

    Laura Bender Somme, Christos Chouaid, ... Roland Schott in BioDrugs
    Article Open access 20 May 2024
  11. Human peritoneal fluid exerts ovulation- and nonovulation-sourced oncogenic activities on transforming fallopian tube epithelial cells

    Secretory cells in the fallopian tube fimbria epithelium (FTE) are regarded as the main cells of origin of ovarian high-grade serous carcinoma...

    Che-Fang Hsu, Vaishnavi Seenan, ... Tang-Yuan Chu in Cancer Cell International
    Article Open access 02 July 2024
  12. Targeting oncogenic TERT promoter variants by allele-specific epigenome editing

    Background

    Activation of dominant oncogenes by small or structural genomic alterations is a common driver mechanism in many cancers. Silencing of such...

    Alexandra G. Kouroukli, Nivethika Rajaram, ... Susanne Bens in Clinical Epigenetics
    Article Open access 22 November 2023
  13. The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain

    MYD88 is the key signaling adaptor-protein for Toll-like and interleukin-1 receptors. A somatic L265P mutation within the Toll/interleukin-1 receptor...

    Marthe Minderman, Hildo Lantermans, ... Steven T. Pals in Blood Cancer Journal
    Article Open access 18 August 2023
  14. Glimmers of hope for targeting oncogenic KRAS-G12D

    KRAS mutations are one of the most common genetic abnormalities in cancer, especially lung, colon, and pancreatic cancers. Strategies targeting the...

    Daolin Tang, Rui Kang in Cancer Gene Therapy
    Article 21 November 2022
  15. The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

    Background

    Metastatic breast cancer is responsible for the death of the majority of breast cancer patients. In fact, metastatic BC is the 2nd leading...

    Wei Wang, Priyanka S. Rana, ... Khalid Sossey-Alaoui in Breast Cancer Research
    Article Open access 22 March 2023
  16. LINC00467: an oncogenic long noncoding RNA

    Long non-coding RNAs (lncRNAs) have been found to play essential roles in the cell proliferation, fission and differentiation, involving various...

    Xuyu Chen, Qian Luo, ... Juan Li in Cancer Cell International
    Article Open access 07 October 2022
  17. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer

    Breast cancer (BC) is the most commonly diagnosed form of cancer and a leading cause of cancer-related deaths among women worldwide. Yes-associated...

    Juan Luo, Hailin Zou, ... Peng Li in British Journal of Cancer
    Article Open access 09 February 2023
  18. Immune escape of avian oncogenic Marek’s disease herpesvirus and antagonistic host immune responses

    Marek’s disease virus (MDV) is a highly pathogenic and oncogenic alpha herpesvirus that causes Marek’s disease (MD), which is one of the most...

    Zhi-Jian Zhu, Man Teng, ... Jun Luo in npj Vaccines
    Article Open access 15 June 2024
  19. Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer

    Background

    Alternative RNA splicing is widely dysregulated in cancers including lung adenocarcinoma, where aberrant splicing events are frequently...

    April Lo, Maria McSharry, Alice H. Berger in BMC Cancer
    Article Open access 16 December 2022
  20. A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma

    Osteosarcoma is the most prevalent malignant bone tumour in children, adolescents and young adults. Despite a multitude of aberrations present in...

    Nikolas Herold in Cancer Gene Therapy
    Article Open access 26 February 2024
Did you find what you were looking for? Share feedback.